Area personale- Login
TagCerca in questo BlogMenuChi può scrivere sul blog
Solo l'autore può pubblicare messaggi in questo Blog e tutti gli utenti registrati possono pubblicare commenti.
|
Post n°1 pubblicato il 17 Maggio 2007 da EryacneGeneric
Tag: Eryacne Generic
Eryacne Generic (also known as eryth ethylsuc) is a macrolide antibiotic which has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, Eryacne Generic has better coverage of atypical organisms, including mycoplasma. Eryacne Generic is also used to treat outbreaks of chlamydia, syphilis, and gonorrhea. Structurally, this macrocyclic compound contains a 14-membered lactone ring with ten asymmetric centers and two sugars (L-cladinose and D-desoamine), making Eryacne Generic a compound very difficult to produce via synthetic methods. Eryacne Generic is produced from a strain of the actinomyces Saccaropolyspora erythraea, formerly known as Streptomyces erythraeus. Eryacne Generic is available in enteric-coated tablets, slow release capsules, oral suspensions, ophthalmic solutions, ointments, gels and injections. Brand names include Robimycin, E-Mycin, E.E.S. Granules, E.E.S.-200, E.E.S.-400, E.E.S.-400 Filmtab, Erymax, Ery-Tab, Eryc, Erypar, EryPed, Eryped 200, Eryped 400, Erythrocin Stearate Filmtab, Erythrocot, E-Base, Ilosone, MY-E, Pediamycin, and PCE Dispertab. Eryacne Generic prevents bacteria from growing, by interfering with their protein synthesis. Eryacne Generic binds to the 23s rRNA molecule in the 50S of the bacterial ribosome, blocking the exit of the growing peptide chain thus inhibiting the translocation of peptides. Eryacne Generic is easily inactivated by gastric acids, therefore all orally administered formulations are given as either enteric coated or as more stable salts or esters. Eryacne Generic is very rapidly absorbed, and diffused into most tissues and phagocytes. Due to the high concentration in phagocytes, Eryacne Generic is actively transported to the site of infection, where during active phagocytosis, large concentrations of Eryacne Generic are released. Most of Eryacne Generic is metabolised by demethylation in the liver. Eryacne Generic main elimination route is in the bile, and a small portion in the urine. Eryacne Generic's half-life is 1.5 hours. Gastrointestinal disturbances such as diarrhea, nausea, abdominal pain and vomiting are fairly common with Eryacne Generic so it tends not to be prescribed as a first-line drug. However, Eryacne Generic may be useful in treating gastroparesis due to this pro-motility effect. Intravenous Eryacne Generic may also be used in endoscopy as an adjunct to clear gastric contents. More serious side-effects of Eryacne Generic, such as reversible deafness are rare. Allergic reactions, while uncommon, may occur, ranging from urticaria to anaphylaxis. Cholestasis, Stevens-Johnson syndrome and toxic epidermal necrolysis are some other rare side effects of Eryacne Generic that may occur. Eryacne Generic has been shown to increase the probability of pyloric stenosis in children whose mothers took the drug during the late stages of pregnancy or while nursing.
You can find more information about this article at: http://www.crdrx.com
Hydrocodone,Lortab,Vicodin,10-325,Norco,Vicoprofen,Xanax,Alprazolam,Diazapam,rx,crdrx,online pharmacy,Anxiety Motivation Clinics,consultation,Pain Medication
|


